The purpose of this study was to examine whether basic fibroblast growth factor (bFGF) stimulates tetrahydrobiopterin (BH4) synthesis in mouse brain microvascular endothelial cells. BH4 content was determined by oxidation ander acidic conditions as biopterin and analysed with reversed-phase high Performance liquid chromatography. Measurement of the mRNA level of QTP-cyclohydrolase 1 (GTPCH), which is the rate-limiting enzyme of the de novo pathway of BH4 synthesis. The addition of bFGF to endothelial cells increased the BH4 content and GTPCH mRNA levels in an incubation period-and a concentration-dependent maimer. 2,4-Diamino-6-hydroxypyrimidine, an inhibitor of GTPCH, strongly reduced the bFGF-mduced increase in BH4 content. These fmdings suggest that bFGF stimulates BH4 synthesis via a de novo pathway with the induction of GTPCH.
Introduction
Basic fibroblast growth factor (bFGF) promotes vascular endothelial cell proliferation, migration, and angiogenesis which is the formation of new capillaries from existing vessels (1) . Angiogenesis is markedly caused under pathological conditions such as solid tumor formation, chronic inflammation, diabetic retinopathy, and ischemia (2). Babaei et al. (3) reported that the underling mechanisms of the bFGF-induced angiogenesis involve the induction of nitric oxide (NO) synthesis, since the bFGF-induced angiogenesis was inhibited by NO synthase Inhibitors. The involvement of NO was also reported in the angiogenesis with various Stimuli, including platelet-activating factor, tumor necrosis factor-a, sphingosine-l-phosphate and angiotensm II (4) (5) (6) . Thus, NO is probably a crucial factor in the promotion of angiogenesis.
Tetrahydrobiopterin (BH4) is an essential cofactor für NO synthase, and an increase in the BH4 level in vascular endothelial cells appears to stimulate NO production (7). Moreover, BH4 has been reported to stimulate cell proliferation in various cells including PC 12, SV40-transfected human fibroblasts and rat glioma cells (8) . We previously reported that an increase in BH4 level stimulates cell proliferation and angiogenesis in bovine aortic endothelial cells (9) . Marrnos et al. (10) also reported that BH4 regulates endothehal cell proliferation via the activation of NO synthase. However, it is unknown whether bFGF increases the BH4 level in vascular endothelial cells and BLk is involved in the Stimulation of endothelial cell proliferation and angiogenesis induced by bFGF.
We investigated herc the effect of bFGF on BH4 synthesis in mouse brain microvascular endothelial cells. The findmgs of the present study show that bFGF incrcascs BH4 content through the induction of GTP-cyclohydrolase I (GTPCH), which is the ratelimiting enzyme of the de novo BH4 synthetic pathway.
Materials and Methods

Cell culture
Mouse brain microvascular endothelial cells (second passage) wcrc purchased from Toyobo Co. (Tokyo, Japan). The cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine scrum (FBS), 100 U/ml penicillin and 100 |ig/ml streptomycin. Cells were finally grown in 100-mm culture dishes to extract total RNA or in 6-well plates to mcasure biopterin content, and used through- out the experiments at 8 to 15 passages after they were purchased.
Measurement of hiopterin level
Confluent endothelial cells in 6-well plates were incubated with FBS-fiee DMEM for 24 h, and then treated with bFGF at 37°C in 2 ml of FBS-frec DMEM. Total biopterin (BH4 and more oxidized species) was measured using an adaptation of the protocol described previously by Heller et al. (11) . The cells in 6-well plates were directiy treated with 0.02 M KI/12 in 0.1 M HCl. Quantification of biopterin was performed by reversed-phase high Performance liquid chromatography (HPLC) with fluorometric detection (12).
Measurement of GTPCH mRNA level.s by Northern blot hybridization
Confluent endothelial cells in 100-mm dishes were incubated with FBS-free DMEM for 24 h, and then treated with bFGF at 37°C in 10 ml of FBS-free DMEM. Total RNA was extracted from the cells by a modified guanidinum isothiocyanatc method with TRIzolä Reagent (GibcoBRL, Gaithersburg, MD, USA). Twenty micrograms of total RNA from each sample were treated with the Solution containing 2.2 M formaldehyde, 50% formamide, 5 mM sodium acetate, 1 mM EDTA and 20 mM 3-morpholinopropanesulfonic acid (MOPS, pH 7.0) for 15 min at 65°C, and the RNA was separated by electrophoresis through a 1% agarose gel containing 2.2 M formaldehyde in MOPS buffer containing 5 mM sodium acetate, 1 inM EDTA and 20 mM MOPS (pH 7.0). The RNA samples were transferred to Hybond-N nylon meinbranes (Amersham Pharmacia Biotech, Buckinghamshire, LIK), and hybndized to the indicated random primelabeled cDNA probe (Takara, Otsu, Japan). The cDNA probes of GTPCH and b-actin were prepared by RT-PCR using pairs of primers of 5'-GGATACCAGGA-GACCATCTCA-3' and 5'-TAGCATGGTGCTAGT-GACAGT-3', and 5'-GTGGGCCGCTCTAGGCAC-CAA-3' and 5'-CTCTTTGATGTCACGCAC-GATTTC-3', respectively, as previously described (12) . Hybridization reactions were camed out for 1 h at 68°C in ExpressHybTM hybridization Solution (CLONTECH Lab., Inc., CA, USA). The membrane was finally washed in O.lx SSC containing 0.1% SDS at 50°C. The washed membrane was exposed to Kodak BiomaxTM fiW at -W^ for UM TW memWane was rc-hybridized by b-actin cDNA, which is a constitutive gene. 
Statistical analysis
Values are presented as means + S.E.M. of n observations. The Statistical significance of observed differences was determined by analysis of variance followed by Bonferroni's method. Differences between means were considered significant when P was less than 0.05.
Results
We examined whether bFGF affects the intracellular biopterin level in endothelial cells. As shown in Fig. lA , the intracellular biopterin level was increased from 9 h after the addition of 25 ng/ml bFGF (Fig. 1A) . The increase in the biopterin level by the treatment with bFGF was observed in a concentration-dependent maimer (Fig. IB) . GTPCH IS the key enzyme of the BH4 synthesis. To clarify whether GTPCH is induced by the treatment with bFGF, the GTPCH mRNA levels were measured by Northern blot analysis (Fig. 2) . The GTPCH mRNA lial cclls increased the intracellular BH4 content. bFGF induced the expression of GTPCH, which is the ratelimiting enzyme for BH4 synthesis, and DAHP, a specific inliibitor of GTPCH activity, inhibited the bFGFinduced increase m the BH4 level. These obscrvations suggcst that bFGF induces BH4 synthesis through the de novo pathway with induction of GTPCH in brain microvascular endothelial cclls. level was increascd from 3 h after the addition of bFGF (25 ng/ml) in an incubation period-dependent manner (Flg. 2A). The concentration-dependent induction of GTPCH mRNA expression was observed (Fig. 2B) . Vloreover, the bFGF-induced increase in biopterin content was strongly reduced by the treatment with DAHP, a selective Inhibitor of GTPCH activity (Fig. 3) 
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Discussion
In the present study, we showed that the addition of bFGF to cultured mouse brain microvascular endothe-10 100 1000 DAHP (nM) bFGF (25 ng/ml) Recent studies have shown that NO has a critical role in the process of angiogenesis induced by various Stimuli, including bFGF, platelet-activating factor, tumor necrosis factor-a and angiotensin II (3-6). Babaei et al. (3) showed that bFGF induces the endothelial-type of NO synthase, and the released NO may act as a crucial signal in the angiogenic response to bFGF, terminating the proliferative actions of angiogenic growth factors and pronioting endothelial cell differentiation into vascular tubes. BH4 is well known to be an essential cofactor for NO synthase, and an increase in the BH4 level can enhance NO production. In the present study, bFGF increased the BH4 level in vascular endothehal cells. It is possible that the increased BH4 is implicated in the bFGF-induced angiogenesis via Stimulation of NO production.
We previously reported that the exogenously added BH4 stimulates cell proliferation and in vitro angiogenesis in bovine aortic endothelial cells (9) . Morinos et al. (10) also reported that BH4 enhances endothelial cell proliferation in rat coronary endothelial cells. Moreover, BH4 has been reported to stimulate cell proliferation in various cell types üicluding PCI2 (8) .
Thus, BH4 appears to have a stimulatory action on proliferation activity. In the present study, bFGF, which is well known to stimulate cell proliferation, increased BH4 content. It is possible that the increased BH4 may be implicated in the bFGF-induced cell proliferation in vascular endothelial cells.
In conclusion, the present fmdings suggested that bFGF induces the increase in BH4 content via a de novo pathway of its synthesis in mouse brain microvascular endothelial cells. The physiological role of the increase in the BH4 content induced by bFGF should be examined in detail in future studies.
